Systematic Reviewhigh evidence
Efficacy and Safety of Glucagon-like Peptide-1 Receptor Agonists and Co-agonists for Weight Loss Among Adults Without Diabetes : An Updated Systematic Review.
Annals of internal medicine·September 1, 2026·PMID 42673585
Why it mattersWith an expanding arsenal of GLP-1-based therapies, clinicians need comparative efficacy and safety data to guide selection among available and emerging agents for weight management in patients without diabetes.
The papers that matter, first.
MedLit ranks the medical literature into a specialty feed with concise summaries, evidence-aware triage, and visual takeaways.
§
MedLit · Evidence, Distilled